Straumann® BLC and TLC Implants SLA Roxolid BL (REF 035.9514S)Recalls & reported problems

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 07630031780171), received between Jul 27, 2026 and Sep 14, 2026 — classified as 3 injuries.

The most frequently reported specific device problem is “Separation Failure” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

• InjurySep 14, 2026Separation Failure

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 50760713 ↗
• InjurySep 14, 2026Separation Failure

  The clinician reports that the day the implant was placed in ADA 13, failure occurred upon insertion. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 50757912 ↗
• InjuryJul 27, 2026Adverse Event Without Identified Device or Use Problem

  The clinician reports that the day the implant was placed in FDI 46, failure occurred upon insertion. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 50042594 ↗